Eye drops, reducing intraocular pressure, today have different mechanisms of action. Some reduce production within the eye, others improve the outflow of products.
Treatment of ocular pressure with drops
Today, eye drops are the only non-surgical method that can effectively reduce intraocular pressure and stop the development of glaucoma. Drugs of domestic or foreign production can be used in treatment - often, there is no difference between them in terms of effectiveness.
Drops to reduce eye pressure by improving fluid outflow
Xalatan
These eye drops from eye pressure are indicated in patients with ophthalmotonus and open-angle glaucoma. They are used for the outflow of liquid, and this mechanism reduces the pressure. Their active ingredient is latanoprost, which contains 50 μg in 1 ml of the preparation. It promotes fluid outflow and is an analogue of prostaglandin F2-alpha.
The drug selectively activates the FP receptors, and causes an increase in the outflow of aqueous humor.
Travatan
These drops, reducing eye pressure, have a similar mechanism of action against ophthalmic hypertension as Xalatan. Travatan drops improve and accelerate the outflow of fluid between the lens and the cornea, thereby preventing or slowing the development of glaucoma.
The active substance drops - travoprost, which is a synthetic analogue of prostaglandin F2-alpha.
Drops to reduce eye pressure by reducing fluid production
Betoptik
These drops belong to selective beta-blockers, and have a completely different mechanism of action than the two previous medicines. Betoptik does not accelerate the outflow of intraocular fluid, but reduces its secretion. Due to this, it is possible to control intraocular pressure within the limits of the norm.
Drugs of this kind are used to treat the initial stage of glaucoma.
The main active substance of drops Betoptik is betaxolol.
Timolol
These drops belong to the group of non-selective beta-blockers. They also, like Betoptik, reduce the production of fluid, which helps reduce intraocular pressure.
Active component of the drug - timolol, which in drops is represented in different concentrations - 2.5% and 5%. Timolol blocks beta-adrenoreceptors and inhibits the production of watery moisture, a large number of which is the cause of increased intraocular pressure.
This drug does not impair visual acuity, and is shown not only in glaucoma, as it reduces both increased and normal pressure.